Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Employee and Director Benefits (Tables)

v3.22.2.2
Note 7 - Employee and Director Benefits (Tables)
9 Months Ended
Sep. 30, 2022
Notes Tables  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

2021

 

Expected volatility

    40.00

%

Expected dividends

    1.78

%

Expected term (in years)

    7.5  

Risk-free rate

    2.43

%

Share-Based Payment Arrangement, Option, Activity [Table Text Block]
                   

Weighted

         
           

Weighted

   

Average

         
           

Average

   

Remaining

   

Aggregate

 
           

Exercise

   

Contractual

   

Intrinsic

 
   

Shares

   

Price

   

Term (years)

   

Value

 
                           

(In Thousands)

 

Nine Months Ended September 30, 2022:

                               

Outstanding at January 1, 2022

    353,250     $ 19.28       3.8     $ 23,525  

Exercised

    (65,500 )     16.42       2.3       4,164  

Forfeited

    (1,500 )     35.21       5.8       67  

Outstanding at September 30, 2022

    286,250       19.51       3.4     $ 18,431  
                                 

Exercisable at September 30, 2022

    225,500     $ 14.89       2.3     $ 14,990  
                                 

Nine Months Ended September 30, 2021:

                               

Outstanding at January 1, 2021

    640,950     $ 18.14       4.6     $ 16,981  

Granted

    500       32.60       7.7       23  

Exercised

    (257,200 )     12.46       3.2       16,805  

Forfeited

    (9,000 )     16.57       2.1       256  

Outstanding at September 30, 2021

    375,250     $ 19.56       4.1     $ 22,438  
                                 

Exercisable at September 30, 2021

    281,000     $ 12.79       3.0     $ 18,565  
Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]
   

Restricted Stock

   

Performance Shares

 
   

Shares

   

Weighted
Average Grant
Date Fair
Value

   

Shares

   

Weighted
Average Grant
Date Fair
Value

 

Nine Months Ended September 30, 2022:

                               

Non-vested at January 1, 2022

    127,602     $ 42.27       12,437     $ 37.05  

Granted

    52,819       83.33       11,415       72.81  

Vested

    (26,563 )     43.51       -       -  

Forfeited

    (8,206 )     61.70       -       -  

Non-vested at September 30, 2022

    145,652     $ 55.84       23,852     $ 54.16  
                                 

Nine Months Ended September 30, 2021:

                               

Non-vested at January 1, 2021

    84,307     $ 34.92       -     $ -  

Granted

    69,295       48.92       12,437       37.05  

Vested

    (13,024 )     28.44       -       -  

Forfeited

    (11,725 )     39.59       -       -  

Non-vested at September 30, 2021

    128,853     $ 42.68       12,437     $ 37.05